Thanks Gunga
Understand what you're saying there re: New targets and upcoming prospects like river crossing. Very early stage and all encouraging. But these will take time and $$$$ to prove up any JORC contributing ounces.
But that's not the part of the ann that created a rush for the exits today for the punters/traders/short term investors
I think the main reason todays announcement was poorly received by the market was the RC results from doubema , foumbiri and pampouna. These prospects were AMX's oxide hopefuls with proximity to konks proposed mine and to be included into PFS (to give the PFS a shot in the arm). It seems those prospects are falling well short of expectations, given the table of significant intercepts in todays ann(most were less than impressive)
I would have to side with the market today regarding the announcement. It was a ST sell if your a trader and a mostly disappointing read for any long-termers that have been dug in waiting for new results....
By no means am I saying that the current shareprice and market cap represents realistic value. I still think that AMX is still stupidly undervalued for the known resources alone, let alone any exploration upside.
Anyway, back to waiting for me and other long term holders. Unfortunately, I don't get paid to wait for the share price to rise , unlike some....(looking at you PK)
Give them some guidance over there please Gunga. They may need it by the looks....
PS: Regarding burkina labs......thats a disgrace how they're run. Time to ship samples to perth or canada ?? I hear Ghana's just as bad as burkina. South africa perhaps ? Labs there must be slowing down with the strikes ?
- Forums
- ASX - By Stock
- AMX
- bleeding
AMX
aerometrex limited
Add to My Watchlist
0.00%
!
21.0¢

bleeding, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.94M |
Open | High | Low | Value | Volume |
20.5¢ | 23.5¢ | 20.0¢ | $15.80K | 76.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1070 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 33238 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1070 | 0.230 |
1 | 2500 | 0.210 |
3 | 34074 | 0.205 |
6 | 391485 | 0.200 |
1 | 5128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 33238 | 1 |
0.240 | 3670 | 1 |
0.250 | 5419 | 2 |
0.265 | 4791 | 1 |
0.275 | 29454 | 1 |
Last trade - 15.22pm 27/06/2025 (20 minute delay) ? |
Featured News
AMX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online